The majority of patients with TTP show severe deficiency in the VWF-cleaving activity of ADAMTS-13, either caused by missense or frame-shift mutations14–16 (Figure 1B) or due to ADAMTS-13 neutralizing autoantibodies.17,18. Here, ADAMTS13 is linked to thrombotic thrombocytopenic purpura.